Literature DB >> 6491605

Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage.

L Larizza, V Schirrmacher, E Pflüger.   

Abstract

A low metastatic, thioguanine-resistant murine T lymphoma line (EbTGR) was hybridized in vitro, with the help of polyethylene glycol, with syngeneic bone marrow-derived macrophages. Two HAT-resistant hybrid lines (Eb-F1 and Eb-F2) were obtained from independent fusion cultures. A cytogenetic analysis revealed that most of the macrophage chromosomes except No. 12 had segregated or become rearranged 60 d after fusion, a time at which the cell lines had become stabilized in culture. Syngeneic mice inoculated subcutaneously with the tumor macrophage hybrid lines developed, very quickly, visceral metastases and died after less than 2 wk, while those inoculated with the parental line lived for greater than 6 wk and developed only localized, large primary tumors. The metastatic hybridomas expressed a similar tumor antigen as a spontaneous, in vivo derived, high metastatic variant (ESb) of the same tumor. This suggests that ESb cells might have arisen from a spontaneous fusion with a host macrophage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491605      PMCID: PMC2187505          DOI: 10.1084/jem.160.5.1579

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. X. Immunoselection of tumor variants differing in tumor antigen expression and metastatic capacity.

Authors:  V Schirrmacher; K Bosslet
Journal:  Int J Cancer       Date:  1980-06-15       Impact factor: 7.396

2.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro.

Authors:  K Bosslet; V Schirrmacher; G Shantz
Journal:  Int J Cancer       Date:  1979-09-15       Impact factor: 7.396

3.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice.

Authors:  V Schirrmacher
Journal:  Int J Cancer       Date:  1979-07-15       Impact factor: 7.396

4.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo.

Authors:  V Schirrmacher; G Shantz; K Clauer; D Komitowski; H P Zimmermann; M L Lohmann-Matthes
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

5.  Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF).

Authors:  H G Meerpohl; M L Lohmann-Matthes; H Fischer
Journal:  Eur J Immunol       Date:  1976-03       Impact factor: 5.532

6.  Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells.

Authors:  P De Baetselier; E Gorelik; Z Eshhar; Y Ron; S Katzav; M Feldman; S Segal
Journal:  J Natl Cancer Inst       Date:  1981-11       Impact factor: 13.506

7.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VIII. Expression and shedding of Fc gamma receptors on metastatic tumor cell variants.

Authors:  V Schirrmacher; W Jacobs
Journal:  J Supramol Struct       Date:  1979

8.  A simple method for fusing human lymphocytes with rodent cells in monolayer by polyethylene glycol.

Authors:  C Brahe; A Serra
Journal:  Somatic Cell Genet       Date:  1981-01

9.  Proof of in vivo fusion of murine tumor cells with host cells by universal fusers.

Authors:  R Ber; F Wiener; E M Fenyö
Journal:  J Natl Cancer Inst       Date:  1978-04       Impact factor: 13.506

10.  Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour.

Authors:  I Parr
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640

View more
  16 in total

1.  Effect of cell fusion on metastatic ability of mouse hepatocarcinoma cell lines.

Authors:  Yan Ji; Mao-Ying Ling; Ying Li; Hong Xie
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

Review 2.  On the origin of cancer metastasis.

Authors:  Thomas N Seyfried; Leanne C Huysentruyt
Journal:  Crit Rev Oncog       Date:  2013

Review 3.  Implications of tumor progression on clinical oncology.

Authors:  D R Welch; S P Tomasovic
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

4.  Microsatellite instability in IVS3 of murine c-fes gene: tumor-associated rearrangement and mammalian divergence.

Authors:  L Volpi; A Beghini; D Rossi; L Larizza
Journal:  Mamm Genome       Date:  1996-09       Impact factor: 2.957

5.  Macrophage Infiltration in Tumor Stroma is Related to Tumor Cell Expression of CD163 in Colorectal Cancer.

Authors:  Ivan Shabo; Hans Olsson; Rihab Elkarim; Xiao-Feng Sun; Joar Svanvik
Journal:  Cancer Microenviron       Date:  2014-04-28

6.  Melanoma x macrophage hybrids with enhanced metastatic potential.

Authors:  M Rachkovsky; S Sodi; A Chakraborty; Y Avissar; J Bolognia; J M McNiff; J Platt; D Bermudes; J Pawelek
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

Review 7.  Perspectives on the mesenchymal origin of metastatic cancer.

Authors:  Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

8.  Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype.

Authors:  Md Zahid Akhter; Surender K Sharawat; Vikash Kumar; Veena Kochat; Zaffar Equbal; Mallika Ramakrishnan; Umesh Kumar; Sandeep Mathur; Lalit Kumar; Asok Mukhopadhyay
Journal:  Oncogene       Date:  2018-01-30       Impact factor: 9.867

9.  Oncogene expression in related cancer lines differing in metastatic capacity.

Authors:  J Pohl; A Radler-Pohl; R Heicappell; V Schirrmacher
Journal:  Clin Exp Metastasis       Date:  1988 May-Jun       Impact factor: 5.150

10.  Malfunctioning CD106-positive, short-term hematopoietic stem cells trigger diabetic neuropathy in mice by cell fusion.

Authors:  Miwako Katagi; Tomoya Terashima; Natsuko Ohashi; Yuki Nakae; Akane Yamada; Takahiko Nakagawa; Itsuko Miyazawa; Hiroshi Maegawa; Junko Okano; Yoshihisa Suzuki; Kazunori Fujino; Yutaka Eguchi; Hideto Kojima
Journal:  Commun Biol       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.